When pharmaceutical companies receive regulatory approval, they are often required by the FDA to monitor how safe and effective the drug is when taken by large numbers of patients. Reducing the time and cost of postmarketing surveillance is a major aim of TARGET PharmaSolutions.
http://wraltechwire.com/target-pharmasolutions-novel-clinical-data-model-helps-drug-industry/16495251/
